Publications & Works

Articles 10
All (10)
SCI-E, SSCI, AHCI (6)
SCI-E, SSCI, AHCI, ESCI (6)
Scopus (6)
Other Publications (4)

9. Refah Devleti ve Sosyal Politikalar

Toplum ve Hekim , vol.20, no.1, pp.20-27, 2005 (Peer-Reviewed Journal)
Papers Presented at Peer-Reviewed Scientific Conferences 8

1. “Biopharmaceutical Financialization and Public Funding of MCMs in Canada during COVID-19 Pandemic”

Society for Social Studies of Science 2022 Annual Conference, 08 December 2022, (Summary Text)

2. “Regulatory Collaboration during COVID-19: Implications for the Future of Health Product Regulation”

Fit for Purpose Regulation Policy Workshop, Dublin, Ireland, 06 November 2022, (Summary Text)

3. “Competitive Interdependence: Political Economy of Drug Regulation during the Pandemic”

Canadian Political Science Association Annual Conference, 2022, 02 June 2022, (Summary Text)

4. Financialisation and Private Equity Fund Investments in the Turkish Healthcare System

7th Annual Conference of the International Initiative for the Promotion of Political Economy, Lizbon, Portugal, 7 - 09 September 2016, (Summary Text)

5. Neoliberalizm Fikri Mülkiyet Hakları ve2000 liyıllarda Türk İlaç Sanayii

13. Sosyal Bilimler Kongresi, Ankara, Turkey, 4 - 06 December 2013, (Full Text)

6. A Political Economy of the recent Changes in the Pharmaceutical Patent Policies across the Developing World and Turkey

British Political Studies Association 54th Annual Conference, LINCOLN, England, 5 - 08 April 2004, (Full Text)

7. Globalisation and Policy Change

Policy and Politics International Conference, Policy and Politics in a Globalised World, Bristol, England, 24 - 26 July 2003, (Full Text)

8. Could Corporatist Associations become Effective Channels of Interest Representation The Case of Turkish Union of Chamber of Pharmacists

Middle East Studies Association of North America 35th Annual Meeting, San-Francisco, Costa Rica, 17 - 21 November 2001, (Full Text)
Books 8

1. Restricted but significant:Financialisation of Households and Retail Banking Activities in Turkey

in: The Political Economy of Financial Transformation in Turkey, G,Yalman,T. Marois,A.R.Gungen, Editor, Routledge, London/New York , London, pp.269-290, 2018

2. Politics, Reforms, and Regulation of Pharma Prices and Expenditures in Turkey over the 2000s.

in: Pharmaceutical Prices in the 21st Century, Z.-U.-D. Babar, Editor, Springer, London/Berlin , Heidelberg, pp.267-295, 2015

3. İlaç Sanayiinde Fikri Mülkiyet Hakları Rejimi ile İlgili Mücadeleler ve Devletin Uluslararasılaşması

in: Türkiye de Sağlık Siyaset ve Piyasa, Gülbiye Yenimahalleli Yaşar, Asuman Göksel, Ömür Birler, Editor, Nota Bene, Ankara, pp.125-172, 2015

4. Neoliberalism, Intellectual Property Rights and the Turkish Pharmaceutical Industry in the 2000s.

in: The New Political Economy of Pharmaceuticals Production Innovation and TRIPS in the Global South, Hans Löfgren and Owain David Williams, Editor, Palgrave Macmillan, London, pp.221-245, 2013

6. Lisbon Strategy and Social Policy in the Enlarged European Union and in Turkey

in: Converging Europe: Transformation of Social Policy in the Enlarged European Union and in Turkey, Ipek Eren Vural, Editor, ASHGATE, SURREY, pp.1-28, 2011

7. Social Outcomes of the Lisbon Strategy and Beyond

in: Converging Europe: Transformation of Social Policy in the Enlarged European Union and in Turkey., Eren Vural,Ipek, Editor, Routledge, London/New York , Oxford, pp.249-261, 2011

8. Siyasal İstikrarın Parlementer Kökenleri:İngiltere Üzerine bir Derleme

in: Başkanlık Sistemi ve Türkiye Ülkeler Deneyimler ve Karşılaştırmalı Analiz, İhsan Kamalak, Editor, SODEV Yayinlari, Kalkedon, İstanbul, pp.21-54, 2007
Metrics

Publication

27

Publication (WoS)

6

Publication (Scopus)

6

Citation (WoS)

41

H-Index (WoS)

2

Citation (Scopus)

60

H-Index (Scopus)

4

Project

4

Thesis Advisory

4

Open Access

5
UN Sustainable Development Goals